[PDF] Top 20 Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
Has 10000 "Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy" found on our website. Below are the top 20 most common "Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy".
Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
... 3. Proliferative fibrovascu- lar membranes and preretinal hemorrhage can be ...PDR, proliferative diabetic retinopathy; NVD, neovascular at the ... See full document
7
<p>Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy</p>
... the effect of selective IVB injection for the prevention of postoperative ...the Diabetic Retinopathy Vitrectomy Study grading system and was de fi ned as a new episode of VH of grade 1 or above ... See full document
8
Aqueous vascular endothelial growth factor and clinical outcomes correlation after single intravitreal injection of bevacizumab in patients with neovascular age-related macular degeneration
... the effect of anti-VEGF therapies on the aqueous and vitreous VEGF levels [23, ...in proliferative diabetic retinopathy, retinopathy of prematurity and neovascular AMD after ... See full document
8
Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy
... to proliferative diabetic retinopathy (PDR) and the efficacy of intravitreal bevacizumab (IVB) for VH in 5- year real- life ...adult patients with type 1 (T1D) or type 2 diabetes ... See full document
6
<p>Vitreous and Serum Concentrations of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Proliferative Diabetic Retinopathy</p>
... that diabetic patients have high serum VEGF levels which will lead to diabetes complications, not only retino- pathy but also nephropathy, neuropathy, atherosclerosis and other vascular ...in ... See full document
6
Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy
... PDR patients was significantly higher than in ...PDR patients are 623 (138–1759) pg/mL and mean serum VEGF levels in PDR patients are 234 (120–509) ... See full document
7
Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy
... mellitus patients without retinopathy (No DR; n = 38), with non-proliferative diabetic retinopathy (NPDR; n = 38), and with proliferative diabetic retinopathy (PDR; ... See full document
6
A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
... In addition to having different efficacies for treating DME, DEX implants and anti-VEGF injection are associ- ated with varying degrees of increased risk of systemic and/or local complications over the period of ... See full document
11
Original Article The effect and safety of intravitreal ranibizumab combined with vitrectomy for proliferative diabetic retinopathy
... tissue growth factor and ...that bevacizumab aggravated the fibro- sis and could promote the hyperplasia deve- ...in patients treat- ed with ranibizumab, but ranibizumab inject- ion increased ... See full document
5
Download Download PDF
... Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and has been investigated as a candidate gene in a number of conditions, including diabetes and its ... See full document
7
Aqueous Interleukin 6 (IL 6) Level Is a Marker for Treatment Resistance to Bevacizumab in Age Related Macular Degeneration —Aqueous Cytokines after Bevacizumab
... the effect of intravitreal bevacizumab on aqueous levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in patients with exudative ... See full document
7
Bevacizumab Inhibits Angiogenic Cytokines in Head and Neck Squamous Cell Carcinoma: From Gene to the Protein
... HN5 cells were cultured into 96-well plates at a density of 2×10 3 per well in DMEM containing 10 % (v/v) FCS and already mentioned antibiotics at 37°C for 24h in an incubator. 24h later, cell medium was replaced with ... See full document
6
Association of the +936 C/T Single Nucleotide Polymorphism of the VEGF-A Gene with Renal Cell Cancer in an Eastern Indian Population
... However, future studies involving longitudinal study designs are needed with larger sample size to establish the results of present study more conclusively. As the C allele in +936 position of the VEGF gene may play a ... See full document
7
Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
... same-day intravitreal injections were usually performed only in patients with sight-threatening ...of intravitreal antibiotics and antivirals for conditions such as viral retinitis and endogenous ... See full document
5
Human Trophoblast Progenitor Cells Express and Release Angiogenic Factors
... Although little is known about trophoblast stem and progenitor cells, mesenchymal stem cells (MSCs) are considerably effective for therapeutic angiogenesis in ischemia animal models as well as clinical vascular ... See full document
9
Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
... years. Patients were analyzed based on three groups: patients who were randomized to the ranibi- zumab group in the MARINA, ANCHOR, and FOCUS trials (n = 600); patients who were in the control groups ... See full document
17
Central subfield thickness and cube average thickness as bioimaging biomarkers for ellipsoid zone disruption in diabetic retinopathy
... of diabetic retinopathy ...of retinopathy, increased CST and CAT and EZ disruption ...that intravitreal ranibizumab led to retinal photoreceptor res- toration and improvement in BCVA in ... See full document
5
Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells
... Vascular endothelial growth factor (VEGF) is a mitogen with a specificity for endothelial cells in vitro and an angiogenic inducer in ...a growth advantage in ...with ... See full document
12
Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies
... or expression in endothelial and tumor cells (Table 5, Figure ...FGF2 expression in cancer cells (Table 5, Figure ...in patients with stage IV metastatic melanoma overexpressing FGF2 (Table 6) ... See full document
28
Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast
... VEGF: vascular endothelial growth factor; VEGF-C: vascular endothelial growth factor-C; VEGFR-l: vascular endothelial growth factor receptor-l (Fit-I); VEGFR-2: vascular e[r] ... See full document
17
Related subjects